-
2024-517614-14-00
4
2025-11-28
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
-
2025-521242-26-00
4
2025-11-27
Moderately to Severely Active Ulcerative Colitis
-
2024-517983-47-00
9
2025-11-25
Myotonic Dystrophy
-
2025-520555-89-00
5
2025-11-14
Metastatic castration-resistant prostate cancer (mCRPC)
-
2025-522135-34-00
11
2025-11-14
Patients undergoing cardiac surgery through conventional median sterno
-
2024-517553-26-00
5
2025-11-12
Advanced ALK-positive non-small cell lung cancer (NSCLC)
-
2024-519345-30-00
5
2025-11-12
IgA nephropathy
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2024-517131-52-00
5
2025-11-03
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lym
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2024-514693-47-01
11
2025-10-28
EGFR mutated locally advanced or metastatic non-small cell lung cancer
-
2024-518004-49-00
9
2025-10-28
Healthy children
-
2024-518365-10-00
5
2025-10-28
Previously Untreated Advanced or Metastatic Non-Squamous Non−Small Cel
-
2024-519495-83-00
4
2025-10-28
Digestive system diseases
-
2024-517140-65-00
9
2025-10-23
Multiple Myeloma (MM).
-
2024-517184-23-00
4
2025-10-16
platinum-resistant advanced high-grade epithelial ovarian, primary per
-
2025-520564-17-00
5
2025-10-16
Hidradenitis suppurativa (HS)
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2023-509175-16-00
5
2025-10-14
Sickle cell disease
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-519190-19-00
4
2025-10-03
Alzheimer’s Disease
-
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
-
2024-519827-16-00
5
2025-09-30
Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients
-
2024-519875-24-00
5
2025-09-26
Carcinoid syndrome